Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies
Compass Therapeutics
Compass Therapeutics
7 Hills Pharma, LLC
IDEAYA Biosciences
InSilico Medicine Hong Kong Limited
Kezar Life Sciences, Inc.
VM Oncology, LLC
Incyte Corporation
Memorial Sloan Kettering Cancer Center
Nurix Therapeutics, Inc.
Incyte Corporation
Incyte Corporation
Context Therapeutics Inc.
NuCana plc
Medicenna Therapeutics, Inc.
Deciphera Pharmaceuticals, LLC
Suzhou Maximum Bio-tech Co., Ltd.
Symphogen A/S
Pfizer
Memorial Sloan Kettering Cancer Center
Institut Bergonié
Quadriga Biosciences, Inc.
Eli Lilly and Company
Shionogi Inc.
Incyte Corporation
Incyte Corporation
Jonsson Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
University of Chicago
Papworth Hospital NHS Foundation Trust
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
Pediatric Brain Tumor Consortium
Wuhan University